Yesterday, Aug. 2, 2016, 97 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $43.70 to $50,903,280.00.

Highlighted Stocks Traded by Insiders:

Ophthotech (OPHT) - FREE Research Report

Patel Samir Chandrakant, who is President at Ophthotech, sold 20,000 shares at $64.21 on Aug. 2, 2016. Following this transaction, the President owned 171,531 shares meaning that the stake was reduced by 10.44% with the 20,000-share transaction.

The shares most recently traded at $64.42, up $0.21, or 0.33% since the insider transaction. Historical insider transactions for Ophthotech go as follows:

  • 4-Week # shares bought: 3,500
  • 4-Week # shares sold: 1,846
  • 12-Week # shares bought: 3,500
  • 12-Week # shares sold: 1.3 million
  • 24-Week # shares bought: 3,500
  • 24-Week # shares sold: 1.4 million

The average volume for Ophthotech has been 477,700 shares per day over the past 30 days. Ophthotech has a market cap of $2.3 billion and is part of the health care sector and drugs industry. Shares are down 18.2% year-to-date as of the close of trading on Friday.

Ophthotech Corporation, a biopharmaceutical company, develops novel therapeutics to treat diseases of the back of the eye. Currently, there are 8 analysts who rate Ophthotech a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OPHT - FREE

TheStreet Quant Ratings

rates Ophthotech as a

sell

. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. Get the full

Ophthotech Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Maxim Integrated Products (MXIM) - FREE Research Report

Wazzan A R Frank, who is Director at Maxim Integrated Products, sold 1,000 shares at $40.77 on Aug. 2, 2016. Following this transaction, the Director owned 114,833 shares meaning that the stake was reduced by 0.86% with the 1,000-share transaction.

The shares most recently traded at $41.09, up $0.32, or 0.78% since the insider transaction. Historical insider transactions for Maxim Integrated Products go as follows:

  • 4-Week # shares sold: 18,000
  • 12-Week # shares sold: 74,473
  • 24-Week # shares sold: 123,545

The average volume for Maxim Integrated Products has been 2.1 million shares per day over the past 30 days. Maxim Integrated Products has a market cap of $11.6 billion and is part of the technology sector and electronics industry. Shares are up 7.32% year-to-date as of the close of trading on Friday.

Maxim Integrated Products, Inc. designs, develops, manufactures, and markets various linear and mixed-signal integrated circuits worldwide. The company also provides a range of high-frequency process technologies and capabilities for use in custom designs. The stock currently has a dividend yield of 3.25%. The company has a P/E ratio of 51.5. Currently, there are 9 analysts who rate Maxim Integrated Products a buy, 3 analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MXIM - FREE

TheStreet Quant Ratings

rates Maxim Integrated Products as a

buy

. The company's strengths can be seen in multiple areas, such as its expanding profit margins, good cash flow from operations, solid stock price performance, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel its strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full

Maxim Integrated Products Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

JetBlue Airways (JBLU) - FREE Research Report

Peterson Joel Clinton, who is Director at JetBlue Airways, sold 5,120 shares at $18.27 on Aug. 2, 2016. Following this transaction, the Director owned 604,893 shares meaning that the stake was reduced by 0.84% with the 5,120-share transaction.

The shares most recently traded at $18.20, down $0.07, or 0.4% since the insider transaction. Historical insider transactions for JetBlue Airways go as follows:

  • 4-Week # shares sold: 6,000
  • 12-Week # shares sold: 17,241
  • 24-Week # shares sold: 38,753

The average volume for JetBlue Airways has been 6.2 million shares per day over the past 30 days. JetBlue Airways has a market cap of $6.0 billion and is part of the services sector and transportation industry. Shares are down 19.07% year-to-date as of the close of trading on Friday.

JetBlue Airways Corporation, a passenger carrier company, provides air transportation services. As of December 31, 2014, the company operated a fleet of 25 Airbus A321 aircrafts, 130 Airbus A320 aircrafts, and 60 Embraer E190 aircrafts. The company has a P/E ratio of 8.3. Currently, there are 6 analysts who rate JetBlue Airways a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on JBLU - FREE

TheStreet Quant Ratings

rates JetBlue Airways as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and notable return on equity. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full

JetBlue Airways Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.